Informed-money record
GENB · Generate Biomedicines, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
2
Named actors
8
Disclosed $ (bull / bear)
$50.3M / $0
Recent disclosures
9 of 9 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-03-13 | Chief Legal Officer and General Counsel Sean Martin | adopted a selling plan | — | SEC ↗ |
| 2026-03-13 | a member of our board of directors Francis Arnold | adopted a selling plan | — | SEC ↗ |
| 2026-03-04 | Chief Executive Officer Nally Michael | bought | $240K | SEC ↗ |
| 2026-03-02 | 10% owner / other Flagship Pioneering Fund VI, L.P. | bought | $25.0M | SEC ↗ |
| 2026-03-02 | Director Mendillo Jane L | bought | $24K | SEC ↗ |
| 2026-03-02 | 10% owner / other Nutritional Health LTP Fund General Partner LLC | bought | $25.0M | SEC ↗ |
| 2026-03-02 | President & CFO Silvers Jason | bought | $8K | SEC ↗ |
| 2026-03-02 | President & CFO Silvers Jason | bought | $16K | SEC ↗ |
| 2026-03-02 | Chief People Officer Grous Beth | bought | $5K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals